187 related articles for article (PubMed ID: 37031346)
21. Boron neutron capture therapy for malignant gliomas.
Diaz AZ; Coderre JA; Chanana AD; Ma R
Ann Med; 2000 Feb; 32(1):81-5. PubMed ID: 10711581
[TBL] [Abstract][Full Text] [Related]
22. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
[TBL] [Abstract][Full Text] [Related]
23. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
Combs SE; Kieser M; Rieken S; Habermehl D; Jäkel O; Haberer T; Nikoghosyan A; Haselmann R; Unterberg A; Wick W; Debus J
BMC Cancer; 2010 Sep; 10():478. PubMed ID: 20819220
[TBL] [Abstract][Full Text] [Related]
24. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
Wang P; Zhen H; Jiang X; Zhang W; Cheng X; Guo G; Mao X; Zhang X
BMC Cancer; 2010 Dec; 10():661. PubMed ID: 21122152
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.
Li R; Wang H; Liang Q; Chen L; Ren J
Biomater Sci; 2022 Feb; 10(4):892-908. PubMed ID: 34989724
[TBL] [Abstract][Full Text] [Related]
26. Deregulated MicroRNA Signature Following Glioblastoma Irradiation.
Toraih EA; El-Wazir A; Abdallah HY; Tantawy MA; Fawzy MS
Cancer Control; 2019; 26(1):1073274819847226. PubMed ID: 31046428
[TBL] [Abstract][Full Text] [Related]
27. BK channels blockage inhibits hypoxia-induced migration and chemoresistance to cisplatin in human glioblastoma cells.
Rosa P; Catacuzzeno L; Sforna L; Mangino G; Carlomagno S; Mincione G; Petrozza V; Ragona G; Franciolini F; Calogero A
J Cell Physiol; 2018 Sep; 233(9):6866-6877. PubMed ID: 29319175
[TBL] [Abstract][Full Text] [Related]
28. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
[TBL] [Abstract][Full Text] [Related]
29. Tumor cell-targeting radiotherapy in the treatment of glioblastoma multiforme using linear accelerators.
Chiang CS; Shih IJ; Shueng PW; Kao M; Zhang LW; Chen SF; Chen MH; Liu TY
Acta Biomater; 2021 Apr; 125():300-311. PubMed ID: 33609743
[TBL] [Abstract][Full Text] [Related]
30. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
[TBL] [Abstract][Full Text] [Related]
31. Effects of low energy protons on clonogenic survival, DSB repair and cell cycle in human glioblastoma cells and B14 fibroblasts.
Moertel H; Georgi JC; Distel L; Eyrich W; Fritsch M; Grabenbauer G; Sauer R
Radiother Oncol; 2004 Dec; 73 Suppl 2():S115-8. PubMed ID: 15971324
[TBL] [Abstract][Full Text] [Related]
32. Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization.
Hinrichs CN; Ingargiola M; Käubler T; Löck S; Temme A; Köhn-Luque A; Deutsch A; Vovk O; Stasyk O; Kunz-Schughart LA
Mol Cancer Ther; 2018 Feb; 17(2):393-406. PubMed ID: 28830984
[TBL] [Abstract][Full Text] [Related]
33. Micro-Vessels-Like 3D Scaffolds for Studying the Proton Radiobiology of Glioblastoma-Endothelial Cells Co-Culture Models.
Akolawala Q; Keuning F; Rovituso M; van Burik W; van der Wal E; Versteeg HH; Rondon AMR; Accardo A
Adv Healthc Mater; 2024 Mar; 13(6):e2302988. PubMed ID: 37944591
[TBL] [Abstract][Full Text] [Related]
34. Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.
Castro-Gamero AM; Borges KS; Moreno DA; Suazo VK; Fujinami MM; de Paula Gomes Queiroz R; de Oliveira HF; Carlotti CG; Scrideli CA; Tone LG
Invest New Drugs; 2013 Aug; 31(4):858-70. PubMed ID: 23299390
[TBL] [Abstract][Full Text] [Related]
35. SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.
Talarico C; Dattilo V; D'Antona L; Barone A; Amodio N; Belviso S; Musumeci F; Abbruzzese C; Bianco C; Trapasso F; Schenone S; Alcaro S; Ortuso F; Florio T; Paggi MG; Perrotti N; Amato R
Oncotarget; 2016 Mar; 7(13):15868-84. PubMed ID: 26908461
[TBL] [Abstract][Full Text] [Related]
36. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
37. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
38. Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition.
Mehta M; Khan A; Danish S; Haffty BG; Sabaawy HE
Mol Cancer Ther; 2015 May; 14(5):1171-80. PubMed ID: 25695954
[TBL] [Abstract][Full Text] [Related]
39. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
[TBL] [Abstract][Full Text] [Related]
40. Boron clusters (ferrabisdicarbollides) shaping the future as radiosensitizers for multimodal (chemo/radio/PBFR) therapy of glioblastoma.
Nuez-Martínez M; Queralt-Martín M; Muñoz-Juan A; Aguilella VM; Laromaine A; Teixidor F; Viñas C; Pinto CG; Pinheiro T; Guerreiro JF; Mendes F; Roma-Rodrigues C; Baptista PV; Fernandes AR; Valic S; Marques F
J Mater Chem B; 2022 Dec; 10(47):9794-9815. PubMed ID: 36373493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
